share

1-(3,5-Dihydroxyphenyl)-2-[[2-(4-Hydroxyphenyl)-1-Methylethyl]Amino]Ethan-1-One Hydrobromide CAS NO 3371-33-3


Unit Price:

CAS No.:3371-33-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

1-(3,5-Dihydroxyphenyl)-2-[[2-(4-Hydroxyphenyl)-1-Methylethyl]Amino]Ethan-1-One Hydrobromide is a high-purity synthetic organic salt with significant pharmacological research interest. This compound matters as a key intermediate or reference standard in the development of novel adrenergic receptor modulators and cardiovascular agents. Pharmaceutical R&D laboratories and fine chemical manufacturers require this material for process development, analytical method validation, and preclinical studies. Its defined structure and purity are critical for ensuring reproducible and reliable research outcomes.

Application

  • Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of advanced drug candidates targeting adrenergic pathways.
  • Reference Standard: Used in analytical chemistry for method development, validation, and quality control (QC) of related active pharmaceutical ingredients (APIs).
  • Biochemical Research: Employed in preclinical studies to investigate receptor binding affinity, selectivity, and metabolic pathways.
  • Process Chemistry: Utilized for scaling up synthetic routes and optimizing yield and purity for GMP manufacturing.
  • Academic Research: A valuable compound for universities and research institutes studying structure-activity relationships (SAR) in medicinal chemistry.
  • Custom Synthesis: Acts as a starting point for the custom synthesis of derivatives and analogs for specialized client projects.

Basic Information

Product Name 1-(3,5-Dihydroxyphenyl)-2-[[2-(4-Hydroxyphenyl)-1-Methylethyl]Amino]Ethan-1-One Hydrobromide
CAS No. 3371-33-3
Molecular Formula C17H20BrNO4
Molecular Weight 382.25 g/mol
Synonyms 1-(3,5-Dihydroxyphenyl)-2-[(2-(4-hydroxyphenyl)-1-methylethyl)amino]ethanone Hydrobromide; 2-[[2-(4-Hydroxyphenyl)-1-methylethyl]amino]-1-(3,5-dihydroxyphenyl)ethanone Hydrobromide; Isoxsuprine Hydrobromide Impurity; Isoxsuprine Related Compound B (Hydrobromide); Adrenergic β2 agonist intermediate; 1-[3,5-Bis(hydroxy)phenyl]-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethanone HBr
EINECS Contact for details

Quality Control

Our 1-(3,5-Dihydroxyphenyl)-2-[[2-(4-Hydroxyphenyl)-1-Methylethyl]Amino]Ethan-1-One Hydrobromide is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets stringent specifications for research and development use. Certificates of Analysis (COA) detailing all test results are available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment. For long-term storage, consider storing under an inert atmosphere to minimize the risk of oxidation.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥98.0%
Water Content (KF) ≤1.0%
Residue on Ignition ≤0.1%
Heavy Metals ≤20 ppm
Related Substances (HPLC) Total impurities ≤2.0%; Any single impurity ≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.